Serum lactate dehydrogenase with a systemic inflammation score is useful for predicting response and survival in patients with newly diagnosed diffuse large B-cell lymphoma.

@article{Jung2015SerumLD,
  title={Serum lactate dehydrogenase with a systemic inflammation score is useful for predicting response and survival in patients with newly diagnosed diffuse large B-cell lymphoma.},
  author={Sung-Hoon Jung and Deok-Hwan Yang and Jae-Sook Ahn and Yeo Kyeoung Kim and Hyeoung-Joon Kim and Je-Jung Lee},
  journal={Acta haematologica},
  year={2015},
  volume={133 1},
  pages={10-7}
}
We evaluated the relationship between serum lactate dehydrogenase (LDH) level with systemic inflammation score and survival in 213 patients with diffuse large B-cell lymphoma (DLBCL) receiving R-CHOP chemotherapy. The patients were classified into 3 groups based on LDH with the Glasgow Prognostic Score (L-GPS). A score of 2 was assigned to patients with elevated C-reactive protein, hypoalbuminemia and elevated LDH, a score of 1 to those with one or two abnormalities and a score of 0 to those… CONTINUE READING